US$ 21.57
fda statement bpc-157 not approved human use If worked as well as the internet says it does… …we'd probably have high quality trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of FDA to discuss easing restrictions
Description
Obesity classification

Susan TREATMENT SUMMARY PROCEDURE TIME Approx
Observed responses in research settings are generally mild and may include temporary administration-site irritation, redness, warmth sensations, local sensitivity, temporary itching, mild fatigue, or response variability depending on research amount, administration frequency, protocol duration, and individual sensitivity

doi: 10.3389/fcimb.2020.589505
